192 related articles for article (PubMed ID: 27060862)
1. Evaluation of soluble glycoprotein V as an in vitro quality marker for platelet concentrates: a correlation study between in vitro platelet quality markers and the effect of storage medium.
Kiminkinen LK; Krusius T; Javela KM
Vox Sang; 2016 Aug; 111(2):120-6. PubMed ID: 27060862
[TBL] [Abstract][Full Text] [Related]
2. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation.
Javela K; Eronen J; Sarna S; Kekomäki R
Transfusion; 2005 Sep; 45(9):1504-11. PubMed ID: 16131384
[TBL] [Abstract][Full Text] [Related]
3. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
4. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
[TBL] [Abstract][Full Text] [Related]
5. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution?
van der Meer PF; Bontekoe IJ; Daal BB; de Korte D
Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624
[TBL] [Abstract][Full Text] [Related]
6. [Qualitative comparison between buffy-coat-collected platelet concentrates and those by single-donor plateletpheresis].
Yu Y; Luo Q; Liu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):878-81. PubMed ID: 17708824
[TBL] [Abstract][Full Text] [Related]
7. Effects of immediate or delayed addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Tully S; Geier C; Hauck B; Weiss D; Callaert M; Eckstein R
Transfusion; 2012 Jun; 52(6):1237-44. PubMed ID: 22070790
[TBL] [Abstract][Full Text] [Related]
8. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
9. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
[TBL] [Abstract][Full Text] [Related]
10. In vitro analysis of volume-reduced washed platelet concentrates stored in bicarbonated Ringer's solution containing less than 5% residual plasma.
Oikawa S; Minegishi M; Endo K; Kawashima W; Suzuki K; Shimizu H
Vox Sang; 2016 Jul; 111(1):16-21. PubMed ID: 26918327
[TBL] [Abstract][Full Text] [Related]
11. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
[TBL] [Abstract][Full Text] [Related]
13. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
[TBL] [Abstract][Full Text] [Related]
14. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
15. Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma.
Gyongyossy-Issa MI; Zhang JG; Culibrk B; Hunter F; Levin E; Scammell K; Weiss S; Holmes DL; Holme S
Vox Sang; 2009 Aug; 97(2):102-9. PubMed ID: 19508670
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
18. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats.
van Rhenen DJ; Vermeij J; Mayaudon V; Hind C; Lin L; Corash L
Vox Sang; 2000; 79(4):206-14. PubMed ID: 11155071
[TBL] [Abstract][Full Text] [Related]
19. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
[TBL] [Abstract][Full Text] [Related]
20. Washing platelets with new additive solutions: aspects on the in vitro quality after 48 hours of storage.
Ringwald J; Althoff F; Zimmermann R; Strasser E; Weisbach V; Zingsem J; Eckstein R
Transfusion; 2006 Feb; 46(2):236-43. PubMed ID: 16441601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
